CClinicalTrials.gg
CompletedNCT06883734Updated Mar 21, 2025

The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia

An interventional study of Illness Management Skills Training in Schizophenia Disorder, sponsored by Neslihan Lok. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-03-21.

Sponsored by Neslihan Lok · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Aug 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study was aimed to examine the effectiveness (illness management and recovery, engulfment, quality of life) of a 12-week the Illness Management Skills Training applied to patients with schizophrenia. The main questions it aims to answer are:

Hypothesis (H1-1): Illness Management Skills Training applied intervention group has lower engulfment than the control group.

Hypothesis (H1-2): Illness Management Skills Training applied intervention group has higher quality of life than the control group.

Hypothesis (H1-3): Illness Management Skills Training applied intervention group has higher illness management and recovery level than the control group.

Researchers were compared the Illness Management Skills Training to a control group (no intervention) to see if the Illness Management Skills Training works on engulfment, quality of life, illness management and recovery in patients with schizophrenia.

Participants were:

  • attended the Illness Management Skills Training, one session per week for 12 weeks, 60 minutes per session, in addition to routine outpatient clinic check-ups.
Read the detailed description

The study examined 110 individuals aged 18-65 who were diagnosed with schizophrenia and applied to the S.U. Faculty of Medicine Mental Health and Diseases Polyclinic in the last year, according to the inclusion-exclusion criteria. A total of 50 individuals diagnosed schizophrenia were included in the study. These individuals were randomly assigned to two groups: intervention and control. Pre-test data were collected using the "Personal Information Form", "Modified Engulfment Scale", "SF 36 Quality of Life Scale" and "Illness Management and Recovery Scale-Patient Form" from the intervention and control groups by researchers between August 2024 and February 2025 in the Group Therapy Room of the Mental Health and Diseases Polyclinic, based on self-reporting. The "Illness Management Skills Training" was applied to the intervention group in 4 groups, one session per week, for a total of 12 weeks. At the end of the Illness Management Skills Training, both the intervention and control groups were administered the "Modified Engulfment Scale", "SF 36 Quality of Life Scale" and "Illness Management and Recovery Scale-Patient Form". No intervention was applied to the control group throughout the 12-week program; the patients continued with their routine outpatient clinic check-ups.

02

Conditions studied

  • Schizophenia Disorder

Browse trials for

Keywords

  • Schizophrenia
  • engulfment
  • quality of life
  • illness management
  • recovery
  • Illness Management Skills Training
  • psychiatric nursing
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 50 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Neslihan Lok is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being between the ages of 18-65,
  • Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
  • Being registered with the Selcuk University Faculty of Medical Hospital Mental Health and Diseases Polyclinic,
  • Coming to the polyclinic for regular check-ups,
  • Getting a mild/moderate score from the Positive and Negative Syndrome Scale (PANSS),
  • Taking medication regularly,
  • Being at least literate.

Exclusion criteria

Exclusion Criteria:

  • Having an organic mental disorder or mental retardation,
  • Having a visual or hearing impairment,
  • Participating in a program similar to the intervention to be implemented.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Intervention

    The intervention group was a group of 25 people consisting of patients with schizophrenia who followed the 12-week Illness Management Skills Training.

    Behavioral: Illness Management Skills Training

  • No intervention
    Control

    The control group consisted of 25 patients with schizophrenia who attended routine outpatient clinic check-ups for 12 weeks without any intervention.

Interventions

  • BehavioralIllness Management Skills Training

    In this study, in addition to routine outpatient clinic check-ups, 12 sessions of Illness Management Skills Training were applied to the intervention group of 25 patients, each in four separate groups of 6+6+6+7 patients (Group 1, Group 2, Group 3, Group 4), once a week, for 60 minutes each. The training consisted of 1) Introduction-Getting Acquainted, 2) Recovery Goals, 3) Understanding Schizophrenia-1, 4) Understanding Schizophrenia-2, 5) Stress Vulnerability Model and Coping with Stress-1, 6) Stress Vulnerability Model and Coping with Stress-2, 7) Learning About Medication, 8) Using Medication Effectively and Monitoring Treatment, 9) Coping with Persistent Symptoms, 10) Recognizing and Monitoring Warning Signs, 11) Warning Signs My Emergency Plan, and 12) Termination sessions.

06

What researchers measure

Primary outcomes

  1. Illness management and recovery total mean score

    The Illness Management and Recovery Scale-Patient Form total score from the scale is 15-75. Increasing scores from the scale indicate that illness management and recovery also increase.

    Time frame: From enrollment to the end of training at 12 weeks

Secondary outcomes

  1. Engulfment total mean score

    The score range of the Modified Engulfment Scale is 25-125. Increasing scores from the scale indicate increased engulfment .

    Time frame: From enrollment to the end of training at 12 weeks

  2. Physical function, social function, physical role difficulty, emotional role difficulty, mental health, energy/vitality, pain and general health Physical and Mental Component Summary Scale mean scores

    The SF 36 Quality of Life scale evaluates quality of life through the sub-dimensions of physical function, social function, physical role difficulty, emotional role difficulty, mental health, energy/vitality, pain and general health. The scale has a physical and mental health summary scale. 0-100 points can be obtained from each sub-dimension. A score of "0" indicates poor health, while a score of 100 indicates good health, and as scores increase, the quality of life also increases.

    Time frame: From enrollment to the end of training at 12 weeks

07

Study locations

1 site
  • Selcuk University Faculty of Medical Hospital
    Konya, 42230, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06883734
Lead sponsor
Neslihan Lok
Collaborators
Selçuk University
Responsible party
Neslihan Lok (Prof. Dr, Study Director, Selcuk University) — Sponsor-investigator
First posted
Mar 19, 2025
Start date
Aug 15, 2024
Primary completion
Jan 31, 2025
Completion
Feb 17, 2025
Last update
Mar 21, 2025

Study contacts

Neslihan Lok, Prof. Dr
study director · Selcuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion